Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GPQ Srl is an Italian medical aesthetics company founded in 1994, best known for its flagship brand WiQo and the patented PRX-T33 needle-free biorevitalization treatment. The company specializes in the research, development, and manufacture of innovative medical devices and cosmeceuticals that promote natural skin regeneration without invasive procedures. Its products, including the PRX-T33 "peel that's not a peel," are distributed in over 45 countries and have been used in millions of treatments worldwide. GPQ focuses on non-invasive solutions for skin aging, melasma, and overall skin health, maintaining a strong presence in the global dermatology and aesthetic medicine markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GPQ.